ReNTox 100u: Pharmacological Profile
Medically Reviewed | Reg. No. 3-5421
Medical-grade botulinum toxin type A formulation. Manufactured by Pharma Research Bio. Engineered for precise neuromodulation in aesthetic and therapeutic clinical applications. High-purity 150 kDa complex, absent of human serum albumin (HSA) and animal-derived proteins.
Chemical Composition
Strain: Clostridium botulinum CBFC26
Molecular Weight: 150 kDa (Lyophilized)
Protein Purity: >99.8%
Excipients: L-methionine, Polysorbate 20
Potency Range: 95-105 units/
Clinical Efficacy Profile
Onset of Action: 24-72 hours
Peak Effect: 10-14 days post-injection
Duration: 6-8 months (patient-dependent)
Diffusion Radius: < 0.5mm
Target Applications: Glabellar lines, axillary hyperhidrosis, cervical dystonia
Administration Protocol & Storage
Reconstitution:
Dilute 100U with 2.5ml sterile, preservative-free 0.9% NaCl. Yields 4U per 0.1ml.
Injection Specifications:
Gauge: 30G-32G. Depth: Intramuscular. Max Dose: 50U per session.
Cold Chain Storage:
Maintain 2°C-8°C. Shelf life: 36 months unopened. Post-reconstitution: use within 24 hours.
Pharmacokinetics:
Inhibits acetylcholine release at the neuromuscular junction via SNAP-25 cleavage.
Medical Restrictions
Contraindicated during pregnancy, lactation, and in patients with known neuromuscular junction disorders (e.g., myasthenia gravis). Concomitant use with aminoglycoside antibiotics requires strict medical supervision. Restricted strictly to licensed medical practitioners. Not authorized for consumer distribution.

Reviews
There are no reviews yet.